All Stories

  1. Mitigating Immunotherapy toxicity with the anti- IL-6R antibody, Tocilizumab

    Article • Journal of Oncology Pharmacy Practice, December 2017, SAGE Publications

    Aparna Hegde

  2. 3A.01 Efficacy of Programmatic Combined Stereotactic Ablative Radiotherapy and Anti- PD-1 Therapy in Advanced Lung Cancer: A Retrospective Analysis

    Article • Journal of Thoracic Oncology, November 2017, Elsevier

    Aparna Hegde

  3. Frailty: the missing piece of the pre- hematopoietic cell transplantation assessment?

    Article • British Journal of Pharmacology, October 2017, Nature

    Aparna Hegde, Hemant Murthy

  4. Outcomes of ERCC1 high locally advanced esophageal cancer patients treated with non-platinum vs platinum based CRT.

    Article • Journal of Clinical Oncology, February 2017, American Society of Clinical Oncology (ASCO)

    Aparna Hegde

  5. PS01.64: Effect of Anti-PD1 Therapy on the Incidence of Thromboembolic Events in Lung Cancer

    Article • Journal of Thoracic Oncology, November 2016, Elsevier

    Aparna Hegde